Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsCyclophosphamideHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesCombined Modality TherapyKidney TransplantationRecurrenceHematopoiesisMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTreatment OutcomeTime FactorsLeukemia, Myeloid, AcuteBone Marrow ExaminationRemission InductionHematologic NeoplasmsImmunosuppressive AgentsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsSurvival AnalysisTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionRetrospective StudiesImmunosuppressionLymphoma, Non-HodgkinLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsAcute DiseaseHeart TransplantationColony-Forming Units AssayT-LymphocytesSevere Combined ImmunodeficiencyChimeraSurvival RateHLA AntigensMyelodysplastic SyndromesBreast NeoplasmsFollow-Up StudiesFlow CytometryLung TransplantationActuarial AnalysisMice, Inbred BALB CHematologic DiseasesCyclosporineBone DensityCell ProliferationCell DifferentiationAntineoplastic AgentsLymphocyte TransfusionDisease-Free SurvivalPrognosisNuclear FamilyNeoplasmsCarmustineOrgan TransplantationPancytopeniaEtoposideGraft vs Tumor EffectCytarabineApoptosisLeukocyte CountGraft vs Leukemia EffectCytomegalovirus InfectionsBone NeoplasmsGranulocyte Colony-Stimulating FactorCell Line, TumorCells, CulturedSpleenBone ResorptionMelphalanLymphomaAntibodies, MonoclonalTumor Cells, Cultured